Innovation and Environmental Sustainability in Healthcare: A Multistakeholder Responsibility
Moderator
Anke-Peggy Holtorf, MBA, PhD, Health Outcomes Strategies, GmbH, Basel, Switzerland
Speakers
Priscille de La Tour, MSc, Sanofi, Lyon, France; Melissa Pegg, BSc, MSc, York Health Economics Consortium, York, United Kingdom; Fiona Adshead, MSc, Sustainable Healthcare Coalition, London, United Kingdom
Issue: Health systems world-wide are under increasing burden due to the impact of climate change on peoples’ health. At the same time, increasing healthcare resource use across the world results in emissions that accelerate climate change and negatively impact the health of current and future generations. In this panel session, we will show-case two/three initiatives that are currently underway to address aspects of environmental sustainability in healthcare: The Sustainable Markets Initiative Health System Task Force (SMI-HSTF), the Sustainable Health Coalition (SHC) and the Environmental Sustainability in Health Technology Assessment Working Group (ESHTA) of Health Technology Assessment international. The discussion will focus on how multi-stakeholder and cross-organisational collaboration can contribute to develop and adopt effective approaches, measures and controls across the innovation life cycle of health technologies for enhancing population health and environmental sustainability.
Overview:
After a brief introduction of the issue, the moderator will invite the representatives of the three initiatives for an eight min overview from their initiative’s perspective. The moderated discussion will then evolve around the opportunities and challenges in each of the multi-stakeholder approaches, how the approaches taken by the initiatives differ or overlap, and what will help to achieve effective complementary pathways and methods that serve the overall common goal. The discussion will also address better integration of environmental sustainability in healthcare and better health of current and future generations. These discussions will include aspects such as feasibility, usefulness, cost, responsibilities, equity, ethics, and learning curves. The audience will be encouraged to join the discussion and in addition, engage through integration of interactive questions.
Code
132
Topic
Health Policy & Regulatory, Health Technology Assessment